Author: Roifman C.M. Schroeder H. Berger M. Sorensen R. Ballow M. Buckley R.H. Gewurz A. Korenblat P. Sussman G. Lemm G. the IGIV-C in PID Study Group
Publisher: Elsevier
ISSN: 1567-5769
Source: International Immunopharmacology, Vol.3, Iss.9, 2003-09, pp. : 1325-1333
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Related content
Safety of IGIV therapy and infusion-related adverse events
Immunologic Research, Vol. 38, Iss. 1-3, 2007-07 ,pp. :
By Meltzer Eli O. LaForce Craig Ratner Paul Price David Ginsberg David Carr Warner
Allergy and Asthma Proceedings, Vol. 33, Iss. 4, 2012-07 ,pp. :
By Berger Melvin Pinciaro Paul J.
Journal of Clinical Immunology, Vol. 24, Iss. 4, 2004-07 ,pp. :
By Kishiyama J.L. Valacer D. Cunningham-Rundles C. Sperber K. Richmond G.W. Abramson S. Glovsky M. Stiehm R. Stocks J. Rosenberg L. Shames R.S. Corn B. Shearer W.T. Bacot B. DiMaio M. Tonetta S. Adelman D.C.
Clinical Immunology, Vol. 91, Iss. 2, 1999-05 ,pp. :
By Brown E. Sherwood Denniston Daren Gabrielson Barry Khan David A. Khanani Sadia Desai Shuchi
Allergy and Asthma Proceedings, Vol. 31, Iss. 4, 2010-07 ,pp. :